According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller ...

Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...

User fee program key to funding for FDA's drug reviews; Talks between FDA, pharma industry for program renewal in 2027 due to begin; FDA job cuts include 15 staff preparing for those talks ...

The reauthorization of FDA’s prescription drug, generics, biosimilar and medical device programs was included in the fiscal 2023 appropriations act, and they are set to expire on Sept. 30, 2027.

FDA staff cuts have claimed negotiators integral to upcoming reauthorization talks on the FDA's funding-dependent user fee program, Reuters reports.

The FDA doesn’t appear to be buying the two year compromise on user fees that the medical device industry is floating in lieu of a full reauthorization of the fees med tech companies pay to the ...

The FDA has explained that user fees facilitate “timely availability of innovative FDA-regulated products without compromising the agency’s commitment to scientific integrity, public health ...

The Food and Drug Administration released a report Thursday containing proposals for reauthorization of the Generic Drug User Fee Act that would accelerate the agency’s drug approval process ...

Under the law, the FDA is required to set a date by which it must make a determination on whether to approve products. In the following years, Congress authorized additional user fee programs for ...

If the FDA charged food companies user fees it could strengthen its oversight of food safety, according to a recent study. The study, “Advancing the FDA’s. Skip to content.

As reports surface detailing the extent of Robert F. | Massive cuts at the FDA have hit staff tied to drug reviews and user fees, putting future approvals in jeopardy, according to multiple reports.